John K. Cini
Director · Sonnet BioTherapeutics Holdings, Inc.
Individual
- 2024
- Dec 3, 2025
- 3
Other insiders active in the same sector
No other insider has filed at John K. Cini's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
- Eric Venker - $65.62M in ROIV purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $63.45M in SEPN purchases and sales in the last 12 months
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John K. Cini?
John K. Cini is a corporate insider, tracked as Director of Sonnet BioTherapeutics Holdings, Inc. (SONN). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did John K. Cini last file a Form 4?
The most recent primary Form 4 on record is dated 3 December 2025, one of 3 filings going back to 2024.
